You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

severe renal impairment

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pain Trial (VX-548)

Not yet recruiting
  • Pain
  • (no location specified)
Jan 19, 2023

Renal Impairment Trial in Miami (Tavapadon)

Recruiting
  • Renal Impairment
  • Jacksonville, Florida
  • +2 more
Jan 18, 2023

Renal Impairment Trial (Emraclidine)

Not yet recruiting
  • Renal Impairment
  • (no location specified)
Jul 17, 2023

Renal Impairment Trial in Miami, Tampa, Philadelphia (Molnupiravir)

Active, not recruiting
  • Renal Impairment
  • Hallandale Beach, Florida
  • +3 more
Feb 2, 2023

Renal Impairment Trial (TNO155)

Not yet recruiting
  • Renal Impairment
  • (no location specified)
Sep 16, 2022

Hyperlipidemia, Mixed Dyslipidemia Trial in Denver (Evolocumab)

Completed
Has Results
  • Hyperlipidemia
  • Mixed Dyslipidemia
  • Evolocumab
  • Denver, Colorado
    Research Site
Nov 3, 2022

Focal Segmental Glomerulosclerosis (FSGS) Trial (IXP)

Not yet recruiting
  • Focal Segmental Glomerulosclerosis (FSGS)
  • (no location specified)
May 9, 2023

Healthy, Renal Impairment Trial in Porto (Cenerimod)

Recruiting
  • Healthy
  • Renal Impairment
  • Porto, Portugal
    BlueClinical Phase 1 Hospital de Prelado
Nov 15, 2022

Trelagliptin Tablets "Survey on Long-term Use in Type 2 Diabetes

Active, not recruiting
  • Type 2 Diabetes Mellitus
  • Tokyo, Japan
    Takeda Selected Site
Oct 28, 2022

COPD Trial (CH6001)

Not yet recruiting
  • Chronic Obstructive Pulmonary Disease
  • (no location specified)
Jul 19, 2022

Renal Impairment Trial in San Antonio (Saroglitazar magnesium)

Recruiting
  • Renal Impairment
  • Saroglitazar magnesium
  • San Antonio, Texas
    American Research Corporation @ Texas Liver Institute
Apr 23, 2022

Renal Impairment Trial in Orlando (TD-4208)

Completed
  • Renal Impairment
  • Orlando, Florida
    Orlando Clinical Research Center (OCRC)
Feb 22, 2022

Renal Impairment Trial (S-217622)

Recruiting
  • Renal Impairment
  • Miami, Florida
  • +3 more
Jan 9, 2023

Renal Impaired, Gilteritinib, Normal Renal Function Trial in Bulgaria, United States (Gilteritinib)

Active, not recruiting
  • Renal Impaired
  • +3 more
  • Garden Grove, California
  • +3 more
Jul 27, 2022

Renal Impairment Trial in Sofia (AZD4831)

Completed
  • Renal Impairment
  • Sofia, Bulgaria
    Research Site
Apr 4, 2022

Renal Impairment, Renal Disease, Kidney Disease Trial in Miami Lakes, Orlando (Nitazoxanide)

Completed
  • Renal Impairment
  • +2 more
  • Miami Lakes, Florida
  • +1 more
Oct 27, 2022

Heart Failure, Renal Insufficiency Trial in Nîmes, Montpellier (Implantation of the CARDIOMEMS™ HF device)

Recruiting
  • Heart Failure
  • Renal Insufficiency
  • Implantation of the CARDIOMEMS™ HF device
  • Nîmes, Gard, France
  • +1 more
Jun 20, 2022

End Stage Renal Disease Trial in Gdansk, Lódz (AZD8233)

Terminated
  • End Stage Renal Disease
  • Gdańsk, Poland
    Research Site
Dec 20, 2022

Renal Impairment Trial in Orlando, Saint Paul (MK-3402)

Terminated
Has Results
  • Renal Impairment
  • Orlando, Florida
  • +1 more
Apr 5, 2022

Renal Insufficiency Trial in Saint Paul (Aztreonam-Avibactam)

Completed
  • Renal Insufficiency
  • Saint Paul, Minnesota
    Prism Research LLC dba Nucleus Network
Nov 2, 2021

Healthy Trial in Munich (ACT-1014-6470 40 mg)

Completed
  • Healthy
  • ACT-1014-6470 40 mg
  • Munich, Germany
    APEX GmbH
Nov 26, 2021

Renal Disease, End Stage Trial in Miami Lakes (Amisulpride IV, Amisulpride Oral Tablet)

Completed
  • Renal Disease, End Stage
  • Amisulpride IV
  • Amisulpride Oral Tablet
  • Miami Lakes, Florida
    Panax Clinical Research
Dec 10, 2021

HIV-1-infection, HIV, HIV I Infection Trial (CAB + RPV)

Not yet recruiting
  • HIV-1-infection
  • +2 more
  • CAB + RPV
  • (no location specified)
Nov 16, 2022

Renal Impairment, Healthy Volunteers Trial in Hialeah, Orlando (Mobocertinib)

Completed
  • Renal Impairment
  • Healthy Volunteers
  • Hialeah, Florida
  • +1 more
May 11, 2022

Multiple Myeloma Trial in Germany, Greece (Daratumumab, Bortezomib, Dexamethasone)

Completed
  • Multiple Myeloma
  • Berlin, Germany
  • +9 more
May 27, 2022